The agency previously argued the merger could harm patients who are prescribed Horizon’s two fastest-growing drugs.
Amgen’s $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement
The agency previously argued the merger could harm patients who are prescribed Horizon’s two fastest-growing drugs.